Temsirolimus

Temsirolimus is a medication used primarily to treat certain types of advanced kidney cancer, particularly renal cell carcinoma. It works by inhibiting a protein called mTOR, which plays a crucial role in cell growth and division. By blocking this protein, temsirolimus slows down the growth of cancer cells and can help shrink tumors. It is usually administered through an intravenous infusion, and patients may need to be monitored for side effects, such as infections or changes in blood counts. Overall, temsirolimus is part of a targeted therapy approach in cancer treatment.